| Fund ID | 805-3172390187 |
| Fund type | Other Private Fund — OTHER INVESTMENT FUND |
| 3(c)(1) exclusion | Yes |
| 3(c)(7) exclusion | No |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| Sales limited to qualified investors | No |
| % of assets independently valued | 100% |
| Owned by the adviser or related persons | 0% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 0% |
| Fund | Type | Gross assets |
|---|---|---|
| Driehaus Life Sciences Master Fund, L.P. | Hedge | $302.3M |
| Driehaus Life Sciences (qp) Fund, L.P. | Hedge | $109.7M |
| Driehaus Associates Fund | Hedge | $9.5M |
Driehaus Emerging Markets Fund, L.P. reports $359.3 million in gross assets, among the top 21% of private funds by size.
The stated minimum investment is $5 million.
Driehaus Emerging Markets Fund, L.P. is managed by Driehaus Capital Management LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.